Concepedia

Steven S. Carroll

SS

64

Publications

5.1K

Citations

35

H-Index

1982

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Arizona State University

Ionis Pharmaceuticals (United States)

Steven S. Carroll is an author at United States Military Academy specializing in medicine, biochemistry, and hepatitis.

ORCID

Top concepts

Publications per year

1982–2024

64

Publications

64

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

Steven D. Young, Susan F. Britcher, L O Tran et al. · Antimicrobial Agents and Chemotherapy · 1995 · 480 citations · Full text

Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs

Steven S. Carroll, Joanne E. Tomassini, Michele Bosserman et al. · Journal of Biological Chemistry · 2003 · 336 citations · Full text

, , +17

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

Giovanni Migliaccio, Joanne E. Tomassini, Steven S. Carroll et al. · Journal of Biological Chemistry · 2003 · 324 citations · Full text

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

David B. Olsen, Anne B. Eldrup, Linda Bartholomew et al. · Antimicrobial Agents and Chemotherapy · 2004 · 233 citations · Full text

, , +15

Rows per page

1–5 of 64